Leveraging RWD can lessen the strain normally put on investigators and sites.
Jennifer Christian, PharmD, PhD
Advertisement
VP of Clinical Evidence and Epidemiology, IQVIA
Articles by Jennifer Christian, PharmD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Artisan Partners’ Director Calls for Novartis Board Shake-Up
2
340B Under Pressure: Inside Pharma's Push for Greater Clarity
3
Kura Oncology Spins Out Caspian Therapeutics With $50 Million to Test Menin Inhibition as a Disease-Modifying Approach to Diabetes
4
The Agentic AI Revolution in Biopharma
5